David Rescott
Stock Analyst at Baird
(2.13)
# 1252
Out of 5,266 analysts
61
Total ratings
60.00%
Success rate
21.22%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Penumbra | Maintains: Strong Buy | 285 325 | 291.22 | 11.6% | 26 | Feb 19, 2025 | |
Medtronic | Maintains: Neutral | 90 91 | 89.73 | 1.42% | 4 | Feb 19, 2025 | |
Inari Medical | Downgrades: Neutral | 81 80 | 79.97 | 0.04% | 4 | Jan 7, 2025 | |
Merit Medical System... | Maintains: Outperform | 107 109 | 103.44 | 5.38% | 2 | Oct 31, 2024 | |
LivaNova | Maintains: Outperform | 66 72 | 47.7 | 50.94% | 3 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 73 68 | 73.45 | -7.42% | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 503 565 | 592.24 | -4.6% | 1 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 90 91 | 104.55 | -12.96% | 4 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 73 71 | n/a | n/a | 8 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 25 26 | 17.64 | 47.39% | 6 | Dec 22, 2023 |